IOVA has doubled in February and broke out above its volume profile high volume area about one week ago as it runs to earnings. Since it settled down two days ago into a relative side- ways consolidation. I will take a long trade here for a pre-earnings play to presume that the buying and bullish momentum will resume nearly immediately.
In a significant stride towards revolutionizing cancer treatment, Iovance Biotherapeutics, Inc. (NASDAQ: NASDAQ:IOVA ) has achieved a monumental milestone. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Iovance's AMTAGVI™ (lifileucel) suspension for intravenous infusion, marking a groundbreaking advancement in the fight against...
Analyzing the options chain of IOVA Iovance Biotherapeutics prior to the earnings report this week, I would consider purchasing the 7.5usd strike price Puts with an expiration date of 2023-6-16, for a premium of approximately $0.70 If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to read...
IOVA formed a large bearish Rising Wedge on this Weekly timeframe This has led to a big downward move, which correlates well with the rising wedge, being a primarily bearish pattern Support has yet to be found on the Weekly timeframe
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic...
Iovance Biotherapeutics aims to improve patient care by making T cell-based immunotherapies broadly accessible for the treatment of patients with solid tumors and blood cancers. Tumor infiltrating lymphocyte (TIL) therapy uses a patient's own immune cells to attack cancer. TIL cells are extracted from a patient's own tumor tissue, expanded through a proprietary...
Hi traders, I would like to share my yesterday´s trade in the IOVA market. We can easily see some relative strength compared to the SPY. (especially during the Coronavirus crisis) -> Long sign. This market went up with confidence and Insiders increased their LONG positions => they believe that their company will rise. So If you want, you can take the trade...
Biotech stocks have shown relentless strength lately, including $IOVA. I wouldn't be surprised to see that IOVA rejects this move downward soon and soars back up (i.e., reverts to trend). That moving average keeps cranking higher.
VIRGIN GALACTIC MRNA APT IOVA STOCK CHARTS!!!
trying rest 21.41 again ..we shall see , but shorts having good day imo or week already